Nexalin Technology, Inc. (NXL)

Market Cap	9.54M -64.3%
Revenue (ttm)	301,647 +78.8%
Net Income	-8.22M
EPS	-0.50
Shares Out	20.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115,137
Open	0.4570
Previous Close	0.4645
Day's Range	0.4480 - 0.4801
52-Week Range	0.3302 - 2.0000
Beta	4.23
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About NXL

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addictio...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 16, 2022
• Employees: 6
• Stock Exchange: NASDAQ
• Ticker Symbol: NXL
• Website: https://www.nexalin.com

Financial Performance

In 2025, Nexalin Technology's revenue was $301,647, an increase of 78.78% compared to the previous year's $168,721. Losses were -$8.22 million, 8.08% more than in 2024.